These startups have seen investment from NEA, Andreessen Horowitz, and DARPA, among many others.
As the digital health sector matures from basic tracking apps into highly regulated medical devices, we are seeing bleeding edge technologies being developed that blur the lines between computers and biology. And a growing share of these startups are beginning to target the brain.
The burgeoning field of neurotechnology involves brain-machine interfaces, neuroprosthetics, neurostimulation, neuromonitoring, and implantable devices intended to not only augment nervous system activity, but expand its capabilities. One such project is Elon Musk’s Neuralink, which is developing “high bandwidth brain-machine interfaces to connect humans and computers.” And even Facebook has announced plans to create brain-machine interfaces that allow users to type using their thoughts.
Below, we used CB Insights data to identify 21 early- and mid-stage neurotech companies working across brain-machine interfaces, neuroprosthetics, neuromonitoring, and neurostimulatory devices.